Related Experiment Videos
Microalbuminuria as a target to improve cardiovascular and renal outcomes
1Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-2372, USA.
Abstract:
Albuminuria is a cardiovascular and renal risk factor in patients with diabetes, patients with hypertension, and the general population. Risk has been shown to increase continuously with increasing urinary albumin levels, starting at levels that once were considered normal. This association is maintained even after adjusting for numerous other factors. Studies also established that a decrease in albuminuria leads to improvement in both cardiovascular and renal outcomes. These data suggest that urinary albumin should be measured routinely and treated to afford cardiovascular and renoprotection.
Insights
Albuminuria indicates increased cardiovascular and kidney risk in diabetes and hypertension patients. Reducing urinary albumin levels improves patient outcomes, suggesting routine monitoring and treatment for protection.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Albuminuria is a recognized risk factor for cardiovascular and renal disease.
- This risk is present in patients with diabetes, hypertension, and the general population.
- The association between albuminuria and risk is continuous, even at previously normal levels.
Purpose of the Study:
- To highlight the significance of albuminuria as a modifiable risk factor.
- To emphasize the benefits of decreasing albuminuria for cardiovascular and renal health.
- To advocate for routine measurement and treatment of albuminuria.
Main Methods:
- Observational studies analyzing urinary albumin levels.
- Risk assessment in patient cohorts with diabetes and hypertension.
- Correlation analysis between albuminuria levels and clinical outcomes.
Main Results:
- Increased urinary albumin levels correlate with higher cardiovascular and renal risk.
- This association persists after adjusting for other risk factors.
- A reduction in albuminuria is linked to improved cardiovascular and renal outcomes.
Conclusions:
- Albuminuria is a critical, independent risk factor for cardiovascular and renal disease.
- Routine monitoring of urinary albumin is recommended for early detection of risk.
- Therapeutic interventions aimed at reducing albuminuria can provide significant renoprotection and cardiovascular protection.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease IV: Nursing Management